Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Meet our Council Members: Derek Foster, ethical and responsible leadership role model

2016-05-18

Mr Derek Foster
Photo: Stephen Collett

Derek Foster was elected to the Council of the University of the Free State (UFS) in October 2012. He was the first Chartered Accountant (South Africa) to be appointed to Council because of the role he could play through his training, background, and experience. In particular, it was his knowledge of corporate governance, ethics, and reporting that led to his serving currently on the Audit and Risk Committee, the Finance Committee, and the Investment Committee of Council.

This Kovsie alumnus qualified as chartered accountant at the UFS in 1978. During his student years, he played rugby for Oud-Studente, and served in the Evening Student Representative Council.

Until December 2010, Derek was a partner in PricewaterhouseCoopers, which he joined in 1972 as a rookie when the company was still known as Meyer, Nel and Co. Nowadays, he is a business consultant and company director, serving on the boards of NWK Limited, Cancer Association of South Africa (national), and Samba Cooperative Limited.

His background and knowledge of auditing shine through strongly when it comes to the manner in which he sees his role as Council member. “The contribution which I can make to the Council of the university is to ensure that management executes strategy and policy appropriately, as formulated and approved by Council, in the best interest of the university community. Of course, this should be done in an ethical, sustainable manner, taking into account the risk environment we find ourselves in. We need to provide ethical leadership, and ensure that the UFS is a responsible corporate institution,” he says.

Work obligations are keeping him very busy, but his four grandsons are equally high on his priority list. He met his wife, Sally, at Kovsies, another reason why the university is close to his heart. “Everything I do, I want to do with enthusiasm and passion, and I want to make a difference wherever I go. I would also like to be a good grandfather, and set a memorable example to my grandchildren,” he says.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept